Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 56151 - 56175 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Panobinostat	Approved Investigational	FGF19	9965	upregulated	panobinostat results in increased expression of FGF19 mRNA	11q13.3	A21037
Panobinostat	Approved Investigational	FGF8	2253	downregulated	panobinostat results in decreased expression of FGF8 mRNA	10q24.32	A21037
Panobinostat	Approved Investigational	FGF9	2254	downregulated	panobinostat results in decreased expression of FGF9 mRNA	13q12.11	A21037
Panobinostat	Approved Investigational	FGFBP3	143282	upregulated	panobinostat results in increased expression of FGFBP3 mRNA	10q23.32	A21037
Panobinostat	Approved Investigational	FGFR3	2261	upregulated	panobinostat results in increased expression of FGFR3 mRNA	4p16.3	A21037
Panobinostat	Approved Investigational	FHOD3	80206	downregulated	panobinostat results in decreased expression of FHOD3 mRNA	18q12.2	A21037
Panobinostat	Approved Investigational	FJX1	24147	downregulated	panobinostat results in decreased expression of FJX1 mRNA	11p13	A21037
Panobinostat	Approved Investigational	FLNB	2317	upregulated	panobinostat results in increased expression of FLNB mRNA	3p14.3	A21037
Panobinostat	Approved Investigational	FLRT2	23768	downregulated	panobinostat results in decreased expression of FLRT2 mRNA	14q31.3	A21037
Panobinostat	Approved Investigational	FLT1	2321	upregulated	panobinostat results in increased expression of FLT1 mRNA	13q12.3	A21037
Panobinostat	Approved Investigational	FNDC5	252995	downregulated	panobinostat results in decreased expression of FNDC5 mRNA	1p35.1	A21037
Panobinostat	Approved Investigational	FOXC1	2296	upregulated	panobinostat results in increased expression of FOXC1 mRNA	6p25.3	A21037
Panobinostat	Approved Investigational	FOXC2	2303	upregulated	panobinostat results in increased expression of FOXC2 mRNA	16q24.1	A21037
Panobinostat	Approved Investigational	FOXD3	27022	upregulated	panobinostat results in increased expression of FOXD3 mRNA	1p31.3	A21037
Panobinostat	Approved Investigational	FOXH1	8928	upregulated	panobinostat results in increased expression of FOXH1 mRNA	8q24.3	A21037
Panobinostat	Approved Investigational	FOXO1	2308	upregulated	panobinostat results in increased expression of FOXO1 mRNA	13q14.11	A21037
Panobinostat	Approved Investigational	FREM1	158326	upregulated	panobinostat results in increased expression of FREM1 mRNA	9p22.3	A21037
Panobinostat	Approved Investigational	FRRS1L	23732	downregulated	panobinostat results in decreased expression of FRRS1L mRNA	9q31.3	A21037
Panobinostat	Approved Investigational	FRZB	2487	downregulated	panobinostat results in decreased expression of FRZB mRNA	2q32.1	A21037
Panobinostat	Approved Investigational	FUT4	2526	upregulated	panobinostat results in increased expression of FUT4 mRNA	11q21	A21037
Panobinostat	Approved Investigational	FUT9	10690	downregulated	panobinostat results in decreased expression of FUT9 mRNA	6q16.1	A21037
Panobinostat	Approved Investigational	FZD10	11211	upregulated	panobinostat results in increased expression of FZD10 mRNA	12q24.33	A21037
Panobinostat	Approved Investigational	FZD2	2535	downregulated	panobinostat results in decreased expression of FZD2 mRNA	17q21.31	A21037
Panobinostat	Approved Investigational	FZD3	7976	downregulated	panobinostat results in decreased expression of FZD3 mRNA	8p21.1	A21037
Panobinostat	Approved Investigational	FZD5	7855	downregulated	panobinostat results in decreased expression of FZD5 mRNA	2q33.3	A21037

Displaying entries 56151 - 56175 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability